NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Seizures and Epilepsy
    Seizures and Epilepsy
    medium
    stethoscope Medicine

    A 28-year-old man with juvenile myoclonic epilepsy (JME) presents for initiation of antiepileptic therapy. He has myoclonic jerks in the morning and occasional generalized tonic-clonic seizures. What is the drug of choice for this patient?

    A. Ethosuximide
    B. Valproic acid
    C. Levetiracetam
    D. Lamotrigine

    Explanation

    ## First-Line Treatment of Juvenile Myoclonic Epilepsy (JME) **Key Point:** Valproic acid is the gold-standard first-line drug for juvenile myoclonic epilepsy because it is the only agent with proven efficacy against all three seizure types in JME: myoclonic jerks, generalized tonic-clonic seizures, and absence seizures. ### Why Valproate for JME? **High-Yield:** Valproic acid is uniquely effective in JME because: - Suppresses myoclonic seizures (other drugs do not) - Controls generalized tonic-clonic seizures - Prevents absence seizures (if present) - Seizure control achieved in >90% of JME patients - Long-term remission possible with valproate monotherapy ### Seizure Types in JME and Drug Efficacy | Seizure Type | Valproate | Levetiracetam | Lamotrigine | Ethosuximide | | --- | --- | --- | --- | --- | | **Myoclonic jerks** | ✓✓ (excellent) | ✓ (partial) | ✗ (ineffective) | ✗ (ineffective) | | **Generalized tonic-clonic** | ✓✓ (excellent) | ✓✓ (excellent) | ✓ (good) | ✗ (ineffective) | | **Absence seizures** | ✓✓ (excellent) | ✗ (ineffective) | ✓ (good) | ✓✓ (excellent) | **Clinical Pearl:** JME is a lifelong condition requiring long-term therapy. Valproate is the only monotherapy that reliably controls all three seizure types, making it the standard of care despite its side-effect profile. ### Valproate in JME: Balancing Risk and Benefit **Warning:** Valproate carries significant risks: - Teratogenicity (10–20% neural tube defects, category X) - Hepatotoxicity (especially in young children <2 years) - Weight gain, tremor, alopecia - Pancreatitis (rare) **Mnemonic:** **V**alproate = **V**ery effective for **J**uvenile **M**yoclonic **E**pilepsy. However, in JME, the benefit of seizure control outweighs these risks. In women of childbearing potential, careful counseling and pregnancy planning are essential; alternatives (levetiracetam + lamotrigine combination) may be considered if pregnancy is planned. ### Why Other Options Are Suboptimal 1. **Levetiracetam:** Broad spectrum but does NOT reliably suppress myoclonic seizures; often requires combination therapy in JME. 2. **Lamotrigine:** Effective for generalized tonic-clonic and absence seizures but ineffective for myoclonic jerks; may even worsen myoclonia in some patients. 3. **Ethosuximide:** Excellent for absence seizures but does NOT control myoclonic jerks or generalized tonic-clonic seizures; inappropriate monotherapy for JME. [cite:Harrison 21e Ch 369]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions